1. Home
  2. PRPO vs SLE Comparison

PRPO vs SLE Comparison

Compare PRPO & SLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPO
  • SLE
  • Stock Information
  • Founded
  • PRPO N/A
  • SLE 2014
  • Country
  • PRPO United States
  • SLE United States
  • Employees
  • PRPO N/A
  • SLE N/A
  • Industry
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • SLE Services-Misc. Amusement & Recreation
  • Sector
  • PRPO Industrials
  • SLE Consumer Discretionary
  • Exchange
  • PRPO Nasdaq
  • SLE Nasdaq
  • Market Cap
  • PRPO 22.0M
  • SLE 3.6M
  • IPO Year
  • PRPO N/A
  • SLE 2019
  • Fundamental
  • Price
  • PRPO $17.55
  • SLE $4.04
  • Analyst Decision
  • PRPO
  • SLE Strong Buy
  • Analyst Count
  • PRPO 0
  • SLE 2
  • Target Price
  • PRPO N/A
  • SLE $100.00
  • AVG Volume (30 Days)
  • PRPO 16.8K
  • SLE 51.3K
  • Earning Date
  • PRPO 11-05-2025
  • SLE 11-13-2025
  • Dividend Yield
  • PRPO N/A
  • SLE N/A
  • EPS Growth
  • PRPO N/A
  • SLE N/A
  • EPS
  • PRPO N/A
  • SLE N/A
  • Revenue
  • PRPO $21,242,000.00
  • SLE $13,576,000.00
  • Revenue This Year
  • PRPO N/A
  • SLE N/A
  • Revenue Next Year
  • PRPO N/A
  • SLE $30.36
  • P/E Ratio
  • PRPO N/A
  • SLE N/A
  • Revenue Growth
  • PRPO 27.05
  • SLE N/A
  • 52 Week Low
  • PRPO $3.90
  • SLE $2.75
  • 52 Week High
  • PRPO $22.38
  • SLE $45.60
  • Technical
  • Relative Strength Index (RSI)
  • PRPO 53.87
  • SLE 60.99
  • Support Level
  • PRPO $19.40
  • SLE $2.89
  • Resistance Level
  • PRPO $22.38
  • SLE $3.25
  • Average True Range (ATR)
  • PRPO 1.39
  • SLE 0.30
  • MACD
  • PRPO -0.01
  • SLE 0.12
  • Stochastic Oscillator
  • PRPO 40.33
  • SLE 88.36

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About SLE Super League Enterprise Inc.

Super League Enterprise Inc is the rocket ship to the metaverse. It is a creator and publisher of content experiences and media solutions across the globe's immersive platforms. Its solutions provide incomparable access to massive audiences that gather in immersive digital spaces to socialize, play, explore, collaborate, shop, learn, and create. The company offers a complete range of development, distribution, monetization, and optimization capabilities designed to engage users through dynamic, energized programs. It generates revenue from advertising, including immersive game world and experience publishing and in-game media products, direct-to-consumer offers, including in-game items, e-commerce, game passes and ticketing and digital collectibles, and content and technology.

Share on Social Networks: